Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Eller

Showing results (71-80 of 88) with videos related to

Pageof 9
Sort By:
Vaccines|May 25, 2024
Safety and Immunogenicity of an Accelerated Ebola Vaccination Schedule in People with and without Human Immunodeficiency Virus: A Randomized Clinical TrialJulie A Ake, Kristopher Paolino, Jack N Hutter, et al.
Plos Pathogens|April 14, 2018
Limited immune surveillance in lymphoid tissue by cytolytic CD4+ T cells during health and HIV diseaseMarcus Buggert, Son Nguyen, Laura M McLane, et al.
Plos Pathogens|May 31, 2023
Viral vector delivered immunogen focuses HIV-1 antibody specificity and increases durability of the circulating antibody recall responseLaTonya D Williams, Xiaoying Shen, Sheetal S Sawant, et al.
The Journal of Infectious Diseases|October 3, 2017
Safety and Immunogenicity of PENNVAX-G DNA Prime Administered by Biojector 2000 or CELLECTRA Electroporation Device With Modified Vaccinia Ankara-CMDR BoostJulie A Ake, Alexandra Schuetz, Poonam Pegu, et al.
Plos Pathogens|September 4, 2020
Adjuvanted HIV-1 vaccine promotes antibody-dependent phagocytic responses and protects against heterologous SHIV challengeKier Om, Dominic Paquin-Proulx, Maria Montero, et al.
Nature Medicine|April 3, 2020
Safety and immunogenicity of Ad26 and MVA vaccines in acutely treated HIV and effect on viral rebound after antiretroviral therapy interruptionDonn J Colby, Michal Sarnecki, Dan H Barouch, et al.
JCI Insight|May 8, 2023
ALVAC-HIV and AIDSVAX B/E vaccination induce improved immune responses compared with AIDSVAX B/E vaccination aloneMargaret C Costanzo, Dominic Paquin-Proulx, Alexandra Schuetz, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Single-cell analyses reveal that monocyte gene expression profiles influence HIV-1 reservoir size in acutely treated cohortsPhilip K Ehrenberg, Aviva Geretz, Meta Volcic, et al.
Nature Communications|May 29, 2025
Single-cell analyses identify monocyte gene expression profiles that influence HIV-1 reservoir size in acutely treated cohortsPhilip K Ehrenberg, Aviva Geretz, Meta Volcic, et al.
Plos Pathogens|December 8, 2020
RV144 HIV-1 vaccination impacts post-infection antibody responsesThembi Mdluli, Ningbo Jian, Bonnie Slike, et al.
Pageof 9

Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Vaccines|May 25, 2024
Safety and Immunogenicity of an Accelerated Ebola Vaccination Schedule in People with and without Human Immunodeficiency Virus: A Randomized Clinical TrialJulie A Ake, Kristopher Paolino, Jack N Hutter, et al.
Plos Pathogens|April 14, 2018
Limited immune surveillance in lymphoid tissue by cytolytic CD4+ T cells during health and HIV diseaseMarcus Buggert, Son Nguyen, Laura M McLane, et al.
Plos Pathogens|May 31, 2023
Viral vector delivered immunogen focuses HIV-1 antibody specificity and increases durability of the circulating antibody recall responseLaTonya D Williams, Xiaoying Shen, Sheetal S Sawant, et al.
The Journal of Infectious Diseases|October 3, 2017
Safety and Immunogenicity of PENNVAX-G DNA Prime Administered by Biojector 2000 or CELLECTRA Electroporation Device With Modified Vaccinia Ankara-CMDR BoostJulie A Ake, Alexandra Schuetz, Poonam Pegu, et al.
Plos Pathogens|September 4, 2020
Adjuvanted HIV-1 vaccine promotes antibody-dependent phagocytic responses and protects against heterologous SHIV challengeKier Om, Dominic Paquin-Proulx, Maria Montero, et al.
Nature Medicine|April 3, 2020
Safety and immunogenicity of Ad26 and MVA vaccines in acutely treated HIV and effect on viral rebound after antiretroviral therapy interruptionDonn J Colby, Michal Sarnecki, Dan H Barouch, et al.
JCI Insight|May 8, 2023
ALVAC-HIV and AIDSVAX B/E vaccination induce improved immune responses compared with AIDSVAX B/E vaccination aloneMargaret C Costanzo, Dominic Paquin-Proulx, Alexandra Schuetz, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Single-cell analyses reveal that monocyte gene expression profiles influence HIV-1 reservoir size in acutely treated cohortsPhilip K Ehrenberg, Aviva Geretz, Meta Volcic, et al.
Nature Communications|May 29, 2025
Single-cell analyses identify monocyte gene expression profiles that influence HIV-1 reservoir size in acutely treated cohortsPhilip K Ehrenberg, Aviva Geretz, Meta Volcic, et al.
Plos Pathogens|December 8, 2020
RV144 HIV-1 vaccination impacts post-infection antibody responsesThembi Mdluli, Ningbo Jian, Bonnie Slike, et al.
Pageof 9